The plain-language read
Hyaluronic acid (HA) is the major glycosaminoglycan of the skin extracellular matrix. With age, HA content decreases, contributing to dehydration and loss of elasticity. Topical HA at multiple molecular weights penetrates differentially: high-MW HA forms a hydrating film on the surface; low-MW HA penetrates the epidermis and stimulates endogenous synthesis.
- HA content declines significantly with age
- Molecular weight determines depth of action
- Polyglutamic acid holds 4x more water than HA per molecule
- HA must be applied to damp skin to function as humectant, not desiccant
Apply HA serum to damp skin and seal with an occlusive (squalane, ceramide cream). In low-humidity environments (sub 50% RH), HA can pull water from the skin if not sealed — context-dependent ingredient.
What this means for your routine
If you're targeting dryness, this research supports adding hyaluronic acid to your AM/PM routine.
If you're targeting dryness, this research supports adding polyglutamic acid to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
HA is the dominant skin GAG and decreases markedly with age. Multiple molecular weights serve distinct functions: HMW HA (>1MDa) provides surface hydration and substantivity; LMW HA (<50kDa) penetrates epidermis and may stimulate endogenous HA synthesis. Crosslinked HA injection remains best-evidence for volumetric correction.
Full abstract→
Hyaluronic acid (HA) is the major glycosaminoglycan of the skin extracellular matrix. With age, HA content decreases, contributing to dehydration and loss of elasticity. Topical HA at multiple molecular weights penetrates differentially: high-MW HA forms a hydrating film on the surface; low-MW HA penetrates the epidermis and stimulates endogenous synthesis. Crosslinked HA injection remains the gold standard for volumetric correction.
Original source →An Injectable Biopolymer Hydrogel Complex (PN/HA/B3) for Facial Skin Redensification and General Rejuvenation: Clinical Report on Device Safety and Efficacy.
This study evaluated the safety and effectiveness of HYDRAGEL A2, an injectable medical device containing hyaluronic acid (HA), polynucleotides (PN), and niacinamide, for improving facial skin quality. These ingredients are increasingly recognized for their synergistic effects in aesthetic medicine, with HA and PN providing hydration and skin support, and niacinamide offering anti-inflammatory and antioxidant properties. A prospective, open-label clinical investigation was conducted on 42 female subjects (mean age 45 ± 1 years, Fitzpatrick skin phototypes II-V) to assess skin elasticity, hydration, and mild skin depression correction following cheek area injections.
Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.
To evaluate the clinical efficacy of device-free auricular acupressure for rosacea and verify its neuroimmunomodulatory effects using serum biomarkers and immediate vascular imaging in a sham-controlled trial. DESIGN, SETTING, AND PARTICIPANTS: This single-center, randomized, sham-controlled, assessor-masked trial was conducted in the Dermatology Outpatient Department of the Second Affiliated Hospital of Xi'an Jiaotong University from October 2025 to May 2026 and included 204 patients with rosacea who were receiving standard first-line treatment. Participants were assigned in a 1:1 ratio using block randomization.
Ergothioneine, collagen peptides, and sodium hyaluronate ameliorate facial skin aging via modulating oxidative stress, inflammation, and extracellular matrix homeostasis.
Skin aging involves intrinsic chronological aging and extrinsic photoaging, characterized by impaired barrier function, extracellular matrix (ECM) degradation, and chronic inflammation. This study evaluated anti-aging efficacy and mechanisms of ergothioneine (EGT), collagen peptides (CP) and sodium hyaluronate (NaHA) using an ex vivo human skin model and a clinical trial. Ex vivo results showed that the EGT+CP+NaHA triple combination (TC) attenuated UV-induced epithelial thinning and collagen fiber disruption.